Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fluid Air develops and supplies advanced powder processing technologies—most notably the PolarDry® electrostatic spray drying system—which enable efficient, low-temperature production of peptides, oligonucleotides, biologics, nutraceuticals and other sensitive compounds. Their technologies are used by leading pharma/biotech manufacturers to improve yield and product quality in commercial-scale manufacturing.
Recent collaborations include strategic agreements with SinoPep Biotech to revolutionize peptide and oligonucleotide production using their proprietary electrostatic drying process.
The company regularly presents at major industry conferences such as TIDES USA and PharmSci360.
No direct clinical results or therapeutic programs exist since they are an equipment/technology supplier.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fluid Air.